Treace Medical Concepts, Inc. TMCI
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 11.63% | -91.20% | 42.33% | 6.38% | -9.27% |
| Total Depreciation and Amortization | 110.01% | -50.28% | -34.92% | 7.84% | 4.67% |
| Total Amortization of Deferred Charges | -7.25% | -75.49% | 1,325.33% | 1.35% | 0.00% |
| Total Other Non-Cash Items | -14.84% | -19.76% | 28.74% | -11.73% | 3.31% |
| Change in Net Operating Assets | -92.42% | 212.36% | -180.85% | -413.29% | -80.66% |
| Cash from Operations | -164.89% | 190.21% | 11.72% | -198.10% | -172.65% |
| Capital Expenditure | 28.12% | -27.69% | 14.63% | 41.07% | -34.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 294.97% | -139.41% | 4.50% | 664.57% | -8.43% |
| Cash from Investing | 190.43% | -180.86% | 10.65% | 368.22% | -71.96% |
| Total Debt Issued | -- | -- | 10,305.26% | -42.01% | -- |
| Total Debt Repaid | 42.27% | 99.18% | -13,768.95% | -317.35% | -- |
| Issuance of Common Stock | -91.21% | 30.00% | -70.95% | 107.76% | -2.52% |
| Repurchase of Common Stock | 87.44% | -176.00% | 81.80% | -2,842.86% | 96.51% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 99.50% | -- | -- | -- |
| Cash from Financing | 218.37% | -142.55% | 13,920.00% | -101.01% | 450.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 363.40% | -138.52% | 925.68% | 93.12% | -363.11% |